Michael Higginbottom

440 total citations
14 papers, 349 citations indexed

About

Michael Higginbottom is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Michael Higginbottom has authored 14 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 8 papers in Oncology. Recurrent topics in Michael Higginbottom's work include Neuropeptides and Animal Physiology (12 papers), Peptidase Inhibition and Analysis (8 papers) and Receptor Mechanisms and Signaling (7 papers). Michael Higginbottom is often cited by papers focused on Neuropeptides and Animal Physiology (12 papers), Peptidase Inhibition and Analysis (8 papers) and Receptor Mechanisms and Signaling (7 papers). Michael Higginbottom collaborates with scholars based in United Kingdom and United States. Michael Higginbottom's co-authors include David C. Horwell, Edward Roberts, Giles S. Ratcliffe, David C. Rees, Nirmala Suman‐Chauhan, David R. Hill, J. C. O’Toole, Clare O. Kneen, William Howson and Martyn C. Pritchard and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Metabolism.

In The Last Decade

Michael Higginbottom

14 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Higginbottom United Kingdom 10 248 190 75 72 27 14 349
Niall M. Hamilton United Kingdom 13 240 1.0× 111 0.6× 143 1.9× 46 0.6× 22 0.8× 30 467
Evangelia Kotsikorou United States 12 236 1.0× 107 0.6× 88 1.2× 74 1.0× 18 0.7× 16 431
V.P. Gerskowitch United Kingdom 14 178 0.7× 129 0.7× 67 0.9× 41 0.6× 50 1.9× 29 426
Elisabeth Greiner United States 14 209 0.8× 175 0.9× 91 1.2× 41 0.6× 97 3.6× 22 518
Anna Wyrębska Poland 12 267 1.1× 191 1.0× 165 2.2× 36 0.5× 52 1.9× 16 557
Cristina Bellucci Italy 14 308 1.2× 110 0.6× 209 2.8× 50 0.7× 36 1.3× 41 516
David M. Bender United States 10 195 0.8× 72 0.4× 118 1.6× 80 1.1× 15 0.6× 14 429
Jean Morrone United States 9 191 0.8× 168 0.9× 138 1.8× 17 0.2× 26 1.0× 9 363
Karen L. Lobb United States 10 210 0.8× 169 0.9× 70 0.9× 26 0.4× 84 3.1× 11 352
Kethireddy V.V. Ananthalakshmi Kuwait 13 147 0.6× 122 0.6× 183 2.4× 39 0.5× 56 2.1× 21 463

Countries citing papers authored by Michael Higginbottom

Since Specialization
Citations

This map shows the geographic impact of Michael Higginbottom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Higginbottom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Higginbottom more than expected).

Fields of papers citing papers by Michael Higginbottom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Higginbottom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Higginbottom. The network helps show where Michael Higginbottom may publish in the future.

Co-authorship network of co-authors of Michael Higginbottom

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Higginbottom. A scholar is included among the top collaborators of Michael Higginbottom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Higginbottom. Michael Higginbottom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ho, Michael G, et al.. (2005). Leptin-mediated inhibition of the insulin-stimulated increase in fatty acid uptake in differentiated 3T3-L1 adipocytes. Metabolism. 55(1). 8–12. 13 indexed citations
2.
Higginbottom, Michael, David C. Horwell, Joel W. Hughes, et al.. (1998). PD 176252 — The first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 8(18). 2589–2594. 45 indexed citations
3.
Hall, Matthew D., Michael Higginbottom, David C. Horwell, et al.. (1996). PD 165929 — the first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonist. Bioorganic & Medicinal Chemistry Letters. 6(21). 2617–2622. 31 indexed citations
4.
5.
Guard, Steven, Michael Higginbottom, David C. Horwell, et al.. (1994). Rational design of high affinity tachykinin NK1 receptor antagonists. Bioorganic & Medicinal Chemistry. 2(5). 357–370. 35 indexed citations
6.
Higginbottom, Michael, et al.. (1993). Conformationally restricted analogues of the potent CCK-B antagonist CI-988. Bioorganic & Medicinal Chemistry. 1(3). 209–217. 7 indexed citations
7.
Boden, P., Michael Higginbottom, David R. Hill, et al.. (1993). Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and mixed CCK-A/CCK-B antagonists. Journal of Medicinal Chemistry. 36(5). 552–565. 56 indexed citations
8.
Higginbottom, Michael, et al.. (1993). Rationally designed ‘dipeptoid’ analogues of cholecystokinin (CCK): C-terminal structure-activity relationships of α-methyl tryptophan derivatives. European Journal of Medicinal Chemistry. 28(1). 47–61. 8 indexed citations
9.
Higginbottom, Michael, et al.. (1993). Rationally designed ‘dipeptoid’ analogues of cholecystokinin (CCK): N-terminal structure-affinity relationships of α-methyl-tryptophan derivatives. European Journal of Medicinal Chemistry. 28(1). 37–45. 8 indexed citations
10.
Higginbottom, Michael, David C. Horwell, & Edward Roberts. (1993). Selective ligands for cholecystokinin receptor subtypes CCK-A and CCK-B within a single structural class. Bioorganic & Medicinal Chemistry Letters. 3(5). 881–884. 9 indexed citations
11.
Higginbottom, Michael, William Nolan, J. C. O’Toole, et al.. (1993). The design and synthesis of kappa opioid ligands based on a binding model for kappa agonists. Bioorganic & Medicinal Chemistry Letters. 3(5). 841–846. 6 indexed citations
12.
Higginbottom, Michael, Clare O. Kneen, & Giles S. Ratcliffe. (1992). Rationally designed dipeptoid analogs of cholecystokinin. A Free-Wilson/Fujita-Ban analysis of some .alpha.-methyltryptophan derivatives as cholecystokinin-B antagonists. Journal of Medicinal Chemistry. 35(9). 1572–1577. 29 indexed citations
13.
Higginbottom, Michael, David R. Hill, David C. Horwell, et al.. (1992). Amide bond replacements incorporated into CCK-B selective "dipeptoids". Journal of Medicinal Chemistry. 35(8). 1472–1484. 50 indexed citations
14.
Horwell, David C., et al.. (1990). α-Methyl tryptophanylphenylalanines and their arylethylamine “dipeptoid” analogues of the tetrapeptide cholecystokinin (30–33). European Journal of Medicinal Chemistry. 25(1). 53–60. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niall M. Hamilton Breakdown of academic impact, for papers by Evangelia Kotsikorou Breakdown of academic impact, for papers by V.P. Gerskowitch Breakdown of academic impact, for papers by Elisabeth Greiner Breakdown of academic impact, for papers by Anna Wyrębska Breakdown of academic impact, for papers by Cristina Bellucci Breakdown of academic impact, for papers by David M. Bender Breakdown of academic impact, for papers by Jean Morrone Breakdown of academic impact, for papers by Karen L. Lobb Breakdown of academic impact, for papers by Kethireddy V.V. Ananthalakshmi
Rankless by CCL
2026